Table 1.
Clinicopathologic Characteristics of Studied Patients
| Clinicopathologic characteristics |
The studied group (n=134) Number (%) |
|---|---|
| Age classes | |
| <60 y | 88 (65.7%) |
| ≥60 y | 46 (34.3%) |
| Sex | |
| Male | 75 (56.0%) |
| Female | 59 (44.0%) |
| Site | |
| Right | 49 (36.6%) |
| Left | 85 (63.4%) |
| Size | |
| Mean ± SD | 6.23±2.73 |
| Min-Max | 1.50-19.00 |
| Histological type | |
| Adenocarcinoma NOS | 110 (82%) |
| Mucinous adenocarcinoma | 18 (13.4%) |
| Signet ring carcinoma | 6 (4.5%) |
| Adenocarcinoma grade | |
| Low | 107 (97.27%) |
| High | 3 (2.7) |
| TILs | |
| Low | 50 (37.3%) |
| Moderate | 51 (38.1%) |
| High | 33 (24.6%) |
| Tumor budding | |
| Low | 90 (67.2%) |
| Moderate | 24 (17.9%) |
| High | 20 (14.9%) |
| Tumor deposits | |
| Present | 15 (11.2%) |
| Absent | 119 (88.8%) |
| Lympho-vascular emboli (LVI) | |
| Present | 79 (59.0%) |
| Absent | 55 (41.0%) |
| Perineural invasion (PNI) | |
| Present | 37 (27.6%) |
| Absent | 97 (72.4%) |
| Tumor depth of invasion | |
| T2 | 17 (12.7%) |
| T3 | 102 (76.1%) |
| T4 | 15 (11.2%) |
| Distant metastasis | |
| M 0 | 126 (94.0%) |
| M 1 | 8 (6.0%) |
| AJCC stage | |
| Stage I | 12 (9.0%) |
| Stage II | 63 (47.0%) |
| Stage III | 51 (38.1%) |
| Stage IV | 8 (6.0%) |
| Clinicopathologic characteristics |
The studied group (n=134) Number (%) |
| Local recurrence | |
| Yes | 31 (23.1%) |
| No | 103 (76.9%) |
| Distant recurrence | |
| Yes | 31 (23.1%) |
| No | 103 (76.9%) |
| Patient fate | |
| Survived | 38 (28.4%) |
| Died | 96 (71.6%) |